Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05354492
Other study ID # IRB00024316
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date February 1, 2021
Est. completion date July 31, 2022

Study information

Verified date April 2022
Source Wake Forest University
Contact Casey Keller, MA
Phone 336-758-5786
Email kellerc@wfu.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

You are invited to participate in a research study involving a new program designed to support people with navigating the changes that can happen after difficult life events. The program activities are aimed at helping you move forward and raise your well-being after experiencing one of life's challenges. This study should not be considered an alternative to any treatment or medication for any disorder or problem.


Description:

Adversity is an inevitable part of human life and can potentially lead to great suffering. However, facing life's challenges also presents the opportunity for lasting and meaningful change. This phenomenon is referred to as posttraumatic growth (PTG) and has been defined as "positive psychological change experienced as the result of the struggle with highly challenging life circumstances" (Tedeschi & Calhoun, 2004). There are several existing psychosocial interventions (e.g., expressive writing) that have been shown to promote PTG, despite not being intentionally designed to do so. Additionally, there have been several interventions developed more recently that specifically target the cultivation of PTG, although many of them have not been extensively tested (Dolbier, Jaggars, & Steinhardt, 2010; Shakespeare-Finch et al., 2014). SecondStory 2.0 is an online group-format intervention that was augmented from the original program (SecondStory) which was designed to promote PTG and well-being in the face of adversity. SecondStory 2.0 incorporates narratives of moral exemplars who have overcome adversity, drawing from recent philosophical explorations that have highlighted the pedagogical functions of such exemplars (e.g. Zagzebski, 2017). This research has focused on their potential to model virtues that consistently characterize individuals who have overcome adversity (e.g. strength, vulnerability, wisdom, love, trust) (Brady, 2018). By including experiences of adversity in these exemplarist narratives, we can theoretically increase an individual's admiration for the exemplar, and in turn enable effective emulation while also broadening his/her understanding of the moral foundations of the human condition (Kidd, 2018). This study will take place remotely via phone and zoom. The initial interview/screening will take place via an online Qualtrics survey (follow-up by phone with the study coordinator), and the intervention sessions will be held online via Zoom with our trained intervention facilitators (licensed therapists). We will also be providing intervention support via a text messaging platform called Mobile Coach. The messages will be the same for all of the participants, and they will all receive them at the same time point in the program. All of the questionnaires will be completed online via a link that will be texted and/or emailed to the participant. Once participants see an advertisement and reach out to our study coordinator about their interest in the study, they will be directed to complete an online prescreening survey via Qualtrics to assess their eligibility for study participation. The study coordinator will then review the online survey and complete the cognitive screener and mental health questions by phone. If participants are eligible after the phone screen with the study coordinator, they will be scheduled to do a safety assessment via phone with one of our study clinicians. Once participants are deemed eligible, they will complete the consent form and be randomized into one of two conditions: active program or control. If a participant is randomized into the control condition, they will be placed on a "wait list" to receive the intervention at a later date. If a participant is randomized into the active program condition, they will be given the schedule for the group sessions, and sent a Zoom link for participation. The group intervention sessions will be guided by our trained facilitators for 75-90 minutes weekly for six weeks. After week 6, participants who were in the active program group will be asked complete a feedback form, as well as to take part in a semi-structured group interview to determine the acceptability and feasibility of the program. They will then enter the follow-up period of the study. Regardless of condition, participants will complete a set of questionnaires at Weeks 0, 3, 6, 9, and 12. After week 12, participants who were randomized to the control condition will receive access to a recorded version of the intervention online. The recorded version will include the intervention developer talking through the intervention content and materials on video. No study participants will be included in this video. This data will help to inform us whether the new improvements made to the SecondStory protocol are effective in improving participants' overall well-being and response to trauma, and will guide any future changes made to the intervention protocol.


Recruitment information / eligibility

Status Recruiting
Enrollment 400
Est. completion date July 31, 2022
Est. primary completion date July 31, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Be at least 18 years old - Have experienced trauma within the last 3 months to 5 years - Feeling some level of subjective distress as a result of the trauma - Read and understand English - Have consistent access to the internet Exclusion Criteria: - Suicide risk - Cognitive Impairment - Diagnosed with a Psychotic Disorder - Diagnosed with moderate to severe PTSD

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Program to Support Well-Being after Adversity
You will be asked to meet on Zoom weekly for 6 weeks with our trained program facilitators along with the other 6-10 members of the intervention group. Meetings will last approximately 75-90 minutes each, and will involve a variety of discussions and activities related to navigating the changes you may face after experiencing a difficult life event. These sessions will be audio-recorded for research purposes and to ensure that facilitators are doing a good job delivering the program.

Locations

Country Name City State
United States Wake Forest University Winston-Salem North Carolina

Sponsors (2)

Lead Sponsor Collaborator
Wake Forest University John Templeton Foundation

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Post-Traumatic Growth We will use the Current-Standing Post-Traumatic Growth Inventory (C-PTGI) 12 weeks
Primary Depression We will use the Patient Health Questionnaire-8 (PHC-8) 12 weeks
Primary Anxiety We will use the Generalized Anxiety Disorder 7-item Scale (GAD-7) 12 weeks
Primary Wellbeing We will use Mental Health Checklist-Short Form (MHC-SF) 12 weeks
Primary Vulnerability We will use the Multidimensional Scale of Perceived Social Support (MSPSS) 12 weeks
Primary Wisdom We will use the Claremont Purpose Scale 12 weeks
Primary Strength We will use the State Hope Scale 12 weeks
Primary Morality We will use the Compassion Scale 12 weeks
Primary Narrative Identity We will code short qualitative responses for Personal Growth, Meaning-Making, Resolution, and Emotional Processing (Positive Reframing) 12 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT04848376 - Post-Market Clinical Follow-up Study of A-SPINE's Products
Terminated NCT03781817 - Intranasal Versus Intravenous Ketamine for Procedural Sedation in Children With Non-operative Fractures Phase 4
Completed NCT04342416 - Using a Brief Visuospatial Interference Intervention to Reduce Intrusive Memories Among Trauma Exposed Women N/A
Recruiting NCT04856449 - DBT Skills Plus EMDR for BPD and Trauma N/A
Completed NCT04356963 - Adjunct VR Pain Management in Acute Brain Injury N/A
Completed NCT05669313 - The Effects of Hypothermia and Acidosis on Coagulation During Treatment With Rivaroxaban Measured With ROTEM
Active, not recruiting NCT03622632 - Pilot Study to Measure Uric Acid in Traumatized Patients: Determinants and Prognostic Association
Recruiting NCT04725721 - Testing FIRST in Youth Outpatient Psychotherapy N/A
Active, not recruiting NCT05530642 - An Augmented Training Program for Preventing Post-Traumatic Stress Injuries Among Diverse Public Safety Personnel N/A
Not yet recruiting NCT05649891 - Checklists Resuscitation Emergency Department N/A
Not yet recruiting NCT03696563 - FreeO2 PreHospital - Automated Oxygen Titration vs Manual Titration According to the BLS-PCS N/A
Withdrawn NCT03249129 - Identification of Autoantibodies and Autoantigens in the Cerebrospinal Fluid of Patients With Spinal Cord Trauma
Completed NCT02240732 - Surgical Tourniquets and Cerebral Emboli N/A
Completed NCT02227979 - Effects of PURPLE Cry Intervention N/A
Withdrawn NCT01169025 - Fentanyl vs. Low-Dose Ketamine for the Relief of Moderate to Severe Pain in Aeromedical Patients N/A
Recruiting NCT01812941 - Evaluation of Mitochondrial Dysfunction in Severe Burn and Trauma Patients N/A
Completed NCT03112304 - Child STEPS for Youth Mental Health in Maine Sustainability N/A
Completed NCT01475344 - Fibrinogen Concentrate (FGTW) in Trauma Patients, Presumed to Bleed (FI in TIC) Phase 1/Phase 2
Completed NCT01210417 - Trauma Heart to Arm Time N/A
Completed NCT01201863 - Neuroendocrine Dysfunction in Traumatic Brain Injury: Effects of Testosterone Therapy Phase 4